|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/08 | (2006.01) |
| A61P 13/12 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/20 | (2006.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Number of the document | 4126932 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21730952.5 |
| Date of filing the European patent application | 2021-06-09 | |
| (97) | Date of publication of the European application | 2023-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation | 2024-02-12 |
| (86) | Number | PCT/EP2021/065462 |
| Date | 2021-06-09 |
| (87) | Number | WO 2021/250097 |
| Date | 2021-12-16 |
| (30) | Number | Date | Country code |
| 20179041 | 2020-06-09 | EP | |
| 20179044 | 2020-06-09 | EP |
| (72) |
WEBER, Marcel , CH
SCHMITT, Simone , CH
ESSLINGER, Christoph , CH
SCHACHTNER, Thomas , CH
HUYNH-DO, Uyen , CH
PROVENZANO, Maurizio , CH
|
| (73) |
Memo Therapeutics AG ,
Wagistrasse 27, 8952 Schlieren,
CH
Universität Bern , Verwaltungsdirektion Hochschulstrasse 6, 3012 Bern, CH Universität Zürich , Prorektorat Forschung Rämistrasse 71, 8006 Zürich, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūno molekulės prieš BK virusą |
| ANTI-BK VIRUS ANTIBODY MOLECULES |
| Payment date | Validity (years) | Amount | |
| 2025-05-27 | 5 | 115.00 EUR |
| 2026-06-09 |